SCHNEYER MARK C. (Chief Financial Officer) sold 5.0% of their position (3.51K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $76.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/5/2026ACC: 0001899977-26-000007
Officer· Chief Financial Officer
Since Dec 2021
-3.51K
Net shares
Net seller
$76.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.82K acquired · 10.32K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.82K
Price / share
—
Trade value
—
% of position
10.8%
5/1/2026
62.84K→69.65K
Common Stock
Direct
Shares
−3.51K
Price / share
$21.79
Trade value
$76.40K
% of position
5.0%
5/4/2026
69.65K→66.14K
Total
Net shares
+3.31K
Net value
-$76.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | M · Option Exercise | +6.82K | — | — | 10.8% | 62.84K | 69.65K |
| Common Stock Direct | 5/4/2026 | S · Sale | −3.51K | $21.79 | $76.40K | 5.0% | 69.65K | 66.14K |
| Total | +3.31K | -$76.40K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.82K shares
Shares
−6.82K
Strike price
Held after
6.82K
Exercisable
—
5/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.82K shares | 5/1/2026 | M · Option Exercise | −6.82K | — | 6.82K |